PC-3M Cells

The PC-3M cell line is a metastatic variant derived from the human prostate adenocarcinoma PC-3 cell line, originally isolated from a bone metastasis of a prostate cancer patient. PC-3M was established to better model the metastatic potential of prostate cancer. This cell line exhibits enhanced migratory and invasive capabilities compared to its parental counterpart, making it a critical tool in studying the molecular mechanisms of metastasis and evaluating therapeutic interventions targeting metastatic prostate cancer. PC-3M cells have been used in various in vitro and in vivo studies to investigate tumor progression and therapeutic resistance mechanisms. They have shown adaptability to diverse culture conditions and exhibit robust growth both in standard culture and in animal models. Notably, the PC-3M line has been widely applied in xenograft studies, where it demonstrates the ability to form tumors and metastasize efficiently, replicating key characteristics of advanced-stage prostate cancer. This makes it an invaluable model for testing anti-metastatic agents and elucidating pathways that drive metastatic dissemination. In addition to its metastatic properties, PC-3M has been utilized to explore interactions between tumor cells and the microenvironment, including the role of stromal cells and extracellular matrix components in promoting cancer progression. The cell line also expresses biomarkers relevant to prostate cancer, such as prostate-specific antigen (PSA), and is amenable to genomic and proteomic profiling, enabling researchers to investigate molecular pathways and identify potential therapeutic targets.